Clinical trial

Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and…

NCT00062231 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Terminated

Key facts

NCT number NCT00062231
Title Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer
Official title Oral Empirical Therapy of Fever in Low-Risk Neutropenic Cancer Patients: A Prospective, Double-Blind, Randomized, Multicenter Trial Comparing Monotherapy (Single Daily Dose Moxifloxacin) With Combination Therapy (Ciprofloxacin Plus Amoxicillin/Clavulanic Acid)
Lead sponsor European Organisation for Research and Treatment of Cancer - EORTC, Other
Status Terminated
Study type Interventional
Conditions Chronic Myeloproliferative Disorders, Fever, Sweats, and Hot Flashes, Infection, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms and 4 more
Intervention type Drug, Procedure
Interventions amoxicillin-clavulanate potassium, ciprofloxacin, moxifloxacin hydrochloride, management of therapy complications
Enrollment 351
Start date Apr 1, 2002
Primary completion Oct 1, 2006
First posted Jun 6, 2003
Last update posted Sep 24, 2012
Countries Belgium, France, Germany, Israel, Italy, Slovakia, Switzerland, Turkey (Türkiye)

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies